# Efficacy and Safety of Garamycin® Sponge in Diabetic Patients With a Moderate or Severe Foot Ulcer Infection

> **NCT01951768** · PHASE4 · COMPLETED · sponsor: **University Hospital, Geneva** · enrollment: 88 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DRUG:** Garamycin Sponge (Gentamicin-Collagen sponge)
- **DRUG:** Systemic Antibiotic

## Key facts

- **NCT ID:** NCT01951768
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2019-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01951768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01951768, "Efficacy and Safety of Garamycin® Sponge in Diabetic Patients With a Moderate or Severe Foot Ulcer Infection". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01951768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*